Gene · 10643
Papers3,038
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,038
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SHMT2 regulates esophageal cancer cell progression and immune Escape by mediating m6A modification of c-myc. | Cell Biosci | 2023 | 37932821 | PubTator, text mining | PubMed |
| Significance of RNA N6-methyladenosine regulators in the diagnosis and subtype classification of coronary heart disease using the Gene Expression Omnibus database. | Front Cardiovasc Med | 2023 | 37928762 | PubTator, text mining | PubMed |
| Regulatory role of RNA modifications in the treatment of pancreatic ductal adenocarcinoma (PDAC). | Heliyon | 2023 | 37928039 | PubTator, text mining | PubMed |
| A TRIM21-based bioPROTAC highlights the therapeutic benefit of HuR degradation. | Nat Commun | 2023 | 37925433 | PubTator, text mining | PubMed |
| FTO facilitates cancer metastasis by modifying the m6A level of FAP to induce integrin/FAK signaling in non-small cell lung cancer. | Cell Commun Signal | 2023 | 37919739 | PubTator, text mining | PubMed |
| Role of m6A modification in regulating the PI3K/AKT signaling pathway in cancer. | J Transl Med | 2023 | 37915034 | PubTator, text mining | PubMed |
| Tumor vaccines: Toward multidimensional anti-tumor therapies. | Hum Vaccin Immunother | 2023 | 37905395 | PubTator, text mining | PubMed |
| GAD1 contributes to the progression and drug resistance in castration resistant prostate cancer. | Cancer Cell Int | 2023 | 37904122 | PubTator, text mining | PubMed |
| RNA N6-methyladenosine modification-based biomarkers for absorbed ionizing radiation dose estimation. | Nat Commun | 2023 | 37903783 | PubTator, text mining | PubMed |
| Comprehensive pan‑cancer analysis of potassium voltage-gated channel Q4 (KCNQ4) gene across multiple human malignant tumors. | Sci Rep | 2023 | 37903775 | PubTator, text mining | PubMed |
| The RNA m6A-Binding Protein YTHDC1 Is Downregulated and Associated With M2 Macrophage Infiltration in Muscle-Invasive Bladder Cancer. | Clin Med Insights Oncol | 2023 | 37901254 | PubTator, text mining | PubMed |
| Isolated Pancreatic Metastasis from a Lung Adenocarcinoma Primary: A Case Report and Literature Review. | Case Rep Oncol | 2023 | 37900790 | PubTator, text mining | PubMed |
| A circular RNA activated by TGFβ promotes tumor metastasis through enhancing IGF2BP3-mediated PDPN mRNA stability. | Nat Commun | 2023 | 37898647 | PubTator, text mining | PubMed |
| A comprehensive prognostic score for head and neck squamous cancer driver genes and phenotype traits. | Discov Oncol | 2023 | 37897503 | PubTator, text mining | PubMed |
| Biomarkers of Tumor Metastasis and Invasiveness. | Cancers (Basel) | 2023 | 37894367 | PubTator, text mining | PubMed |
| Comprehensive Transcriptomic Profiling of m6A Modification in Age-Related Hearing Loss. | Biomolecules | 2023 | 37892219 | PubTator, text mining | PubMed |
| METTL3-regulated m6A modification impairs the decidualization of endometrial stromal cells by regulating YTHDF2-mediated degradation of FOXO1 mRNA in endometriosis-related infertility. | Reprod Biol Endocrinol | 2023 | 37891533 | PubTator, text mining | PubMed |
| N6-methyladenosine-modified oncofetal lncRNA MIR4435-2HG contributed to stemness features of hepatocellular carcinoma cells by regulating rRNA 2'-O methylation. | Cell Mol Biol Lett | 2023 | 37891494 | PubTator, text mining | PubMed |
| Filter and Wrapper Stacking Ensemble (FWSE): a robust approach for reliable biomarker discovery in high-dimensional omics data. | Brief Bioinform | 2023 | 37889118 | PubTator, text mining | PubMed |
| Cyclosporin A inhibits prostate cancer growth through suppression of E2F8 transcription factor in a MELK‑dependent manner. | Oncol Rep | 2023 | 37888771 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10643/papers?page=26